Rarity PBC

About Rarity PBC

Rarity PBC is a mission-driven public benefit biotech company dedicated to developing life-saving gene therapies for rare diseases, with a focus on ensuring accessibility and affordability for all patients.

Products & Services

Gene Therapies:Therapies that modify or replace faulty genes to correct the root cause of rare diseases, offering potential for lasting or curative effects unlike traditional symptom management treatments.

Specialties

Gene Therapy Rare Diseases Accessible and Affordable Treatments

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 4600000 MR: - FA: 4.6 million FAN: 4600000	D: 2025-10-29 FD: 2025-10-29	2 investors

Seed Latest

2025-10-29

$4.6M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Paul Ayoub

Chief Executive Officer and Co-founder

K

Katelyn Masiuk

Chief Scientific Officer and Co-founder

R

Roger Hollis

Viral Vector Advisor, Co-founder

D

Donald B Kohn

Scientific Development Advisor, Co-founder

A

Andrea Spezzi, M.D

Business & Clinical Development

A

Anne-Virginie Eggimann

Regulatory Development

View 5 more team members with Pro

Unlock Full Team Directory

Recent News

Rarity PBC Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised